ChronVac-C: Phase I/II ongoing

Tripep received approval from the Swedish regulatory authority to give 3 patients in the highest dose (1,500 µg) group of an ongoing Phase I/II trial a fifth dose of ChronVac-C. A total of 12 treatmen...